ZENGAC 500mg Injection Vial

Frequently asked questions

• Onset of action

  The peak effect of this medicine can be observed immediately after intravenous infusion.

• Duration of Effect

  The effect of this medicine lasts for an average duration of 12 to 24 hours.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit forming tendency has been reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to ZENGAC 500mg Injection Vial or any other inactive ingredients present along with the formulation.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

• Ototoxicity

  This medicine should be used with caution in patients because it may alter the hearing ability if particularly it is used more than 10 days

• Impaired kidney function

  This medicine may increase the risk of kidney injury, especially in the elderly population. The dose of this medicine should be adjusted based on the creatinine clearance (CrCl). Any signs and symptoms of kidney injury like fluid accumulation, weight gain should be reported to the doctor.

• Drug-resistance

  Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug-resistant.

• Neutropenia

  This medicine should be used with caution in patients with pre-existing neutropenia due to an increased risk of a further decrease in leukocyte count and therapy should be discontinued if needed.

• Driving or operating machinery

  Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during or immediately after treatment with this medicine.

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• practo.com - Vancomycin [Internet]. Available from: https://www.practo.com/medicine-info/vancomycin-285-api [cited 6/8/2020]. 2017
• dailymed.nlm.nih.gov - Vancomycin [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06dcfd36-942f-4752-86ad-4c5a6fc3e48f [cited 6/8/2020]. 2018
• medlineplus.gov - Vancomycin [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a604038.html [cited 6/8/2020]. 2016